U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.134T>C (p.Leu45Pro) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Sep 1, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000235508.12

Allele description [Variation Report for NM_000546.6(TP53):c.134T>C (p.Leu45Pro)]

NM_000546.6(TP53):c.134T>C (p.Leu45Pro)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.134T>C (p.Leu45Pro)
HGVS:
  • NC_000017.11:g.7676235A>G
  • NG_017013.2:g.16316T>C
  • NM_000546.6:c.134T>CMANE SELECT
  • NM_001126112.3:c.134T>C
  • NM_001126113.3:c.134T>C
  • NM_001126114.3:c.134T>C
  • NM_001126118.2:c.17T>C
  • NM_001276695.3:c.17T>C
  • NM_001276696.3:c.17T>C
  • NM_001276760.3:c.17T>C
  • NM_001276761.3:c.17T>C
  • NP_000537.3:p.Leu45Pro
  • NP_000537.3:p.Leu45Pro
  • NP_001119584.1:p.Leu45Pro
  • NP_001119585.1:p.Leu45Pro
  • NP_001119586.1:p.Leu45Pro
  • NP_001119590.1:p.Leu6Pro
  • NP_001263624.1:p.Leu6Pro
  • NP_001263625.1:p.Leu6Pro
  • NP_001263689.1:p.Leu6Pro
  • NP_001263690.1:p.Leu6Pro
  • LRG_321t1:c.134T>C
  • LRG_321:g.16316T>C
  • LRG_321p1:p.Leu45Pro
  • NC_000017.10:g.7579553A>G
  • NM_000546.4:c.134T>C
  • NM_000546.5:c.134T>C
Protein change:
L45P
Links:
dbSNP: rs879254066
NCBI 1000 Genomes Browser:
rs879254066
Molecular consequence:
  • NM_000546.6:c.134T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.134T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.134T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.134T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.17T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.17T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.17T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.17T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.17T>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000293353GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Nov 2, 2015)
germlineclinical testing

Citation Link,

SCV004141816CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Uncertain significance
(Sep 1, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000293353.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is denoted TP53 c.134T>C at the cDNA level, p.Leu45Pro (L45P) at the protein level, and results in the change of a Leucine to a Proline (CTG>CCG). This variant not, to our knowledge, been published in the literature as either a pathogenic germline variant or a benign polymorphism. TP53 Leu45Pro was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. Since Leucine and Proline differ in some properties, this is considered a semi-conservative amino acid substitution. TP53 Leu45Pro occurs at a position that is not conserved and is located within the region of interaction with HRMT1L2 (UniProt). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Based on currently available evidence, it is unclear whether TP53 Leu45Pro is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV004141816.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

TP53: PM2

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Oct 20, 2024